CSL Limited JP Morgan Conference 2020

CSL Limited, a global leader in plasma therapies and influenza vaccines, presents at the JP Morgan Conference. The company holds the #1 position in plasma therapies with ~$8.5bn in annual revenues across 100+ countries and operates 8 major manufacturing sites.